In 1997, Dolly the sheep became a scientific sensation when her birth was announced. Yet unlike other sheep, or any life form for that manner, Dolly was the first mammal cloned from an adult cell and, at the time, was a great stride for science and genetics. Or was it? Ever since, heated debates have argued the ethics of cloning. Dolly's early death in 2003 only in 2003 only added fuel to the fire, as there were now questions about the long term health of clones.

Earlier this year, BioTech Inc. announced a significant breakthrough in the world of genetics and cloning with a new version of DNA splicing, BioTech had created a process in which they spliced DNA, then replaced and modified certain genes before reconnecting the DNA. While many questioned the process, BioTech silenced all critics when it showcased a public demonstration in which an adult chimpanzee was cloned.

Since then, the debate over genetics has reached an all-time high, spreading over into other facets of American life. In the world of sports, for example, the question of genetic enhancements to athletes has been brought up and now is being argued by owners and players alike.

Genetics is evolving at a rate much faster than any other field. With the cloning of the BioTech chimpanzee, there are now few who doubt that human cloning will one day be possible, especially since chimpanzees are so similar to humans. Yet, what will happen when that day comes? Will the technology be hailed or shunned? One can only wait and see.